Echo45 Advisors LLC increased its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 25.9% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,562 shares of the company’s stock after buying an additional 321 shares during the quarter. Echo45 Advisors LLC’s holdings in Procter & Gamble were worth $258,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. RPg Family Wealth Advisory LLC bought a new position in Procter & Gamble in the third quarter valued at about $33,000. Costello Asset Management INC increased its position in shares of Procter & Gamble by 2,142.9% during the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company’s stock valued at $54,000 after purchasing an additional 300 shares during the last quarter. William B. Walkup & Associates Inc. bought a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $58,000. Mendota Financial Group LLC boosted its holdings in shares of Procter & Gamble by 58.0% in the fourth quarter. Mendota Financial Group LLC now owns 376 shares of the company’s stock worth $63,000 after buying an additional 138 shares during the last quarter. Finally, Itau Unibanco Holding S.A. increased its holdings in Procter & Gamble by 138.7% during the third quarter. Itau Unibanco Holding S.A. now owns 401 shares of the company’s stock valued at $69,000 after buying an additional 233 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Price Performance
Shares of Procter & Gamble stock opened at $164.41 on Friday. The stock has a 50 day moving average of $168.96 and a 200 day moving average of $169.36. The Procter & Gamble Company has a 12 month low of $152.06 and a 12 month high of $180.43. The firm has a market cap of $387.20 billion, a PE ratio of 26.18, a PEG ratio of 3.69 and a beta of 0.45. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.49.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a yield of 2.45%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.01%.
Insider Buying and Selling at Procter & Gamble
In other news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now owns 11,595 shares in the company, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.18% of the company’s stock.
Analyst Ratings Changes
Several brokerages have recently weighed in on PG. DA Davidson reiterated a “buy” rating and set a $209.00 price target on shares of Procter & Gamble in a research note on Thursday. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Morgan Stanley lifted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Evercore ISI increased their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Finally, Barclays upped their price objective on Procter & Gamble from $155.00 to $159.00 and gave the stock an “equal weight” rating in a research note on Thursday. Eight research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $180.53.
Check Out Our Latest Research Report on Procter & Gamble
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- ESG Stocks, What Investors Should Know
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.